chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shingles; Little soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) and VACCINATION SITE PAIN (Little soreness in the arm) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DOFETILIDE, APIXABAN (ELIQUIS), LOSARTAN and METOPROLOL for an unknown indication.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-May-2021, the patient experienced HERPES ZOSTER (Shingles) and VACCINATION SITE PAIN (Little soreness in the arm). The patient was treated with VALACYCLOVIR [VALACICLOVIR] for Shingles, at a dose of 1 gram and TRIAMCINOLONE for Shingles, at a dose of 0.1 %. At the time of the report, HERPES ZOSTER (Shingles) and VACCINATION SITE PAIN (Little soreness in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow-up information received on 14 May 2021 contains no new information. On 15-Jul-2021: Follow-up information received on 15 Jul 2021 contains Non-significant information.
Patient received first dose of vaccine on 2-12 (lot EN6201) in right deltoid. Patient was administered a  vaccine for his second COVID shot instead of other COVID-19 vaccine.
Severe local reaction to Varivax 10 x 14cm redness, induration, swelling, warmth and pain over injection site. Central area of vesicular - like rash. 4 x 4cm, dizzy, HA, longer temp. Began within 18 hours of injection.
Employee received a mandatory flu shot, 2 days later at the siite she had swelling redness and itching involving the entire upper arm.. She has never had an issue with flu shot before.
Pain, swelling, area hurt and felt numb.  General malaise for 2-3 days.
p/vax pt devel D; then hematochezia; seen by GI; milk protein intolerance; devel failure to thrive & recurrence of hematochezia;
pt recvd vax; w/in 2 hrs of vax had tightness in chest; cough, blood shot eyes, puffy eyelids; body aches & fever; felt bad for about 7 days;
Patient advises they received the vaccination on 12/24/2020 and 2 days later 12/26/2020 the soreness from the injection was gone. He advised that 3 days after the soreness resolved it returned on 12/29/2020. The patient said he has not experienced any swelling, fever, or inflammation;however, he is still experiencing soreness.
Around 11:30pm 1/25, I muttered "I don't feel good," which reminded me of being a child getting sick. within 30 minutes of then end escalating over the next hour, I had a severe headache, bilateral, occipital, pressure in entire head and neck. The headache as also in my eyes and in my ears.  Back was also painful - not as bad as neck, but i can't explain how horribly a hope a massage could fix me.  There was no comfortable position to alleviate any of that.  I also got the chills, constantly, suddenly switching from shivering cold to so hot i needed to take blankets off - but soon as i took the blankets off I'd be freezing cold again. I was also super nauseous, though i didn't vomit. I pretty much couldn't get out of bed much for 24-36 hours. During that time, i was unable to sleep as well, i think mostly due to the chills, constantly having to move about to keep warm or cool off, but not sure.      I did take acetaminophen around 10pm 1/26 (36 hours after injection)- i felt like I knew you're not supposed to, but I couldn't take it any more and it might have less anti-inflammatory impact than ibuprofen.  It dulled the pains some, but didn't make it stop. the chills and nausea mostly stopped and was able to sleep more the second night, last night.       I'm now up and trying to work today (1/27). Head still has pressure headache throughout. Neck is still sore, like a pressure headache. I feel generally foggy and heavy.
Employee stated she began to feel increased pain in the left arm/shoulder making it difficult for her to lift her arm.
Pt received ZOSTAVAX on Tues, 5/3/11. He noticed a shingles-like rash on his (L) butt cheek on Fri, 5/6/11. On Mon 5/9/11 he saw his Dr. who diagnosed the rash as shingles & gave him an rx for 7-day course of valacyclovir.
Redness and swelling (R) upper thigh on 9/20/13 pm and 9/21 AM. Warm to touch, very painful. No fevers beyond low grade. Increased pain on 9/22. Mom took him to ER on 9/22. X-ray of knee neg. Labs showed mild bumps in ESR and CRP. Blood culture neg after 5 days.
Pt recv'd his 2nd dose of Pnu-Imune on 1/31/00. On 2/1/00, he was admitted to hosp w/ cellulitis of rt arm occuring after the vaccine was administered. It involved the entire rt arm & hand.
Congestive heart failure; shingles; other zoster-related conditions; Information has been received from a lawyer regarding a case in litigation referring to a patient (pt.) of unknown age and gender. There was no information provided about the pt's concurrent conditions, concomitant therapies, historical drugs, drug reactions or allergies, or pertinent medical history. On or around 01-OCT-2013, the pt. was inoculated by a healthcare provider (HCP) with zoster vaccine live (ZOSTAVAX) injection (strength, dosage, route of administration, anatomical site of vaccination, lot number, and expiration date were not reported) at a clinic for the long-term prevention of shingles and zoster-related conditions. On an unknown date, subsequently to the vaccine inoculation, the pt. was treated by a physician in a hospital for shingles (herpes zoster), congestive heart failure (cardiac failure congestive) and other zoster-related conditions (ill-defined disorder). As a direct and proximate result of pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, the pt. had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of the events was not reported. The reporter considered the events to be related to vaccination with zoster vaccine live (ZOSTAVAX).  Upon internal review, event cardiac failure congestive was determined to be medically significant.
Narrative:  COVID infection following COVID vaccine series 03/01, Pfizer, dose #1 04/05, Pfizer, dose #2 08/30 pt cc: cough, headache, fatigue, exposure:  unknown 08/30 COVID swab, result: detected 08/30 SARS-COV-2 Variant Sequencing result: pending
Narrative:  68-year-old male with PMH of Bilateral knee pain, Sensory hearing loss, Gastroesophageal reflux disease, History of gastrointestinal bleed, and Elevated blood-pressure reading without diagnosis of hypertension who presented to ED for chest pain. Approximately 1 hour prior to arrival, patient was walking down the stairs when he began feeling lightheadedness with a racing heart beat and palpitations. Palpitations were associated with moderate left-sided chest pain that did not radiate as well as difficulty taking a full inspiration. In addition, he described feeling generalized weakness with tingling of his right hand. These symptoms lasted approximately 5-10 minutes at their worst and subsequently started to improve. He does state that he has had nasal congestion over the past 4 days however denies fever or cough and states he has been in his normal health up until today. No history of anticoagulation, DVT, PE. When EMS arrived, patient was mildly tachycardic however able to ambulate and communicate in full. He is not hypotensive or hypoxic. Diagnosed with extensive PE and right RLE DVT. Treated with IV heparin, transitioned to oral apixaban.
It was reported that a traveling health nurse who was providing TB screening to employees at a daycare center, stated that after several complaints of severe burning upon administration, she discovered that she was in fact, injecting influenza (Fluzone SV '99-'00). A 39 year old female states that she experienced "arm swelling" and pain immediately, post vax, which she treated with hot/cold compresses. She awoke at 03:00 with nausea and vomiting, headache and flu-like symptoms. She does state that she is recovering from bronchitis/flu and is being treated with "Zylex". Pt has received influenza vaccination in the past and has experienced similar symptoms. She has a positive history of Asthma (treated with albuterol PRN). She also states that she had HTN but it is medicated. Follow up #1  06/04/02: during internal auditng of all fines, it was deemed necessary to amend the report by updating the Adverse Event coding. (Added medication error, nausea and vomiting.
pt recvd vax 24AUG93 & 3 wks following the vax pt exp pain when opening & closing hand; MD reported in f/u that the pt had a question of arthritis & aching joints on 19OCT93; lab eval revealed ESR 6 & a neg ANA of 1:40;
The day after receiving FLUMIST, noticed eye redness (mild) and itching. 6 days after vaccine, noticed tiny yellow pustules under eyes and continued to have pain and itching in eyes. He went to urgent care and diagnosed with allergic reaction, prescribed allergy eye drops.
Information has been received from a nurse concerning a 14 year old female who on 13-JUN-2007 was vaccinated with a 0.5 ml first dose of Gardasil.  On 14-AUG-2007 the patient was vaccinated with a 0.5 ml second dose of Gardasil (Lot # 658282/0929U).  Concomitant medication included MENACTRA.  On 14-AUG-2007 the patient's family member called the office and reported that the patient felt dizzy and was acting loopy after the second dose.  Unspecified medical attention was sought.  Subsequently, the patient recovered.  She did not report a similar experience after the first dose.  Additional information has been requested.
Diarrhea, fever then 18 days later sore throat, dizziness, vomiting.
patient came into office for a booster dose of Hep B after having her titers drawn for medical school, she was given a the pediatric dose of Hep B instead of a adult dose . informed patient, contacted pharmacy to inquire if the pediatric dose  will cover her additional dose needed for Hep B
ATAXIA; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A 5 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ATAXIA (hospitalization), outcome "unknown", described as "ATAXIA".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a nurse practitioner refers to a college aged patient. The patient was intramuscularly vaccinated wit a 0.5 ml second dose of M-M-R II (lot number not reported) on 12-JUL-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse effect was reported. No treatment information was reported. Additional information has been requested.
look at testimonials on here of how it doesn't prevent you from getting shingles/Suspected vaccination failure; look at testimonials on here of how it doesn't prevent you from getting shingles; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included taste disorder (refer case US2021AMR203490) and smell loss (refer case US2021AMR203490).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. As per the patient, look at testimonials on here of how it did not prevent you from getting shingles. The patient was injured from the vaccine. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR203490:Same reporter, same patient, different event
COVID INFECTION Narrative: COVID infection after completion of COVID vaccine series 02/17 COVID vaccine dose #1 03/10 COVID vaccine dose #2 04/06 COVID positive test after c/o Pfizer immunization series completed on 3/10/2021. Sx started 4/1/2021 with diarrheal stools described as bloody. He went to ER related to ongoing diarrheal stools 4/6/2021 his labs were uneventful except for COVID test positive. Today the patient denies diarrheal stools (reports "just stopped). 04/11: COVID infection clinically resolved Only symptom reported was dry cough.
17 year old patient received the 2nd dose of Moderna COVID vaccine. No adverse events reported
Chills; Dry heaving; Low-grade fever; Diarrhea; This is a spontaneous report from contactable other health professional. This female other HCP (patient) of unspecified age reported for herself that she received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2nd Dose, Single Dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, after receiving her second dose of the Pfizer-BioNTech COVID-19 vaccine-the patient experienced chills, dry heaving, low-grade fever, diarrhea for three days. The outcome of the events was unknown.  Information about batch/lot number has been requested.  Follow-up attempts are completed. No further information is expected.
Painful hanging nodule near injection site. Skin infections, many requiring antibiotics and aspiration. Later development of CIN III (Within 2 years).
Systemic: Tinnitus-Medium, Additional Details: He said it started within an hour of receiving the second dose. It gets very loud and comes and goes. Its usually more noticeable at night and sounds like high pitched crickets.
I got COVID even though I was vaccinated; I got COVID even though I was vaccinated; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: (Unknown). The reporter is the patient.  An elderly female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "I got COVID even though I was vaccinated". Clinical course: Unknown Title: Creative Spark Testing 2023. Unknown name: Covid-19 Patient Community for 2023. Vendor name (privacy). Patient identifier: Respondent Serial private. Age group: Elderly (greater and equals to 65 years). Age was unknown. Reported that got covid after vaccine. About her own covid journey and the fact that she got covid even though she was vaccinated and praised God for the vaccine because without it, she believed she wouldn't be here. It was unknown if the reporter considered the event as caused by the suspect product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
weakness in legs/body (noodle legs). It stopped after I ate dinner and rested a couple of hours, (so it started about 2 hours after the shot, and stopped about 4 hours after).
fever; fatigue; muscle aches; flu like symptoms; arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN IN EXTREMITY (arm soreness), PYREXIA (fever), FATIGUE (fatigue) and MYALGIA (muscle aches) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 004NI20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN IN EXTREMITY (arm soreness), FATIGUE (fatigue) and MYALGIA (muscle aches). On 27-Feb-2021, the patient experienced PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 28-Feb-2021, PYREXIA (fever) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN IN EXTREMITY (arm soreness), FATIGUE (fatigue) and MYALGIA (muscle aches) outcome was unknown.            No concomitant provided. Action taken with mRNA-1273 in responsible to the events were not applicable
rash on chest and back; Fever; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on chest and back) and PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (rash on chest and back) and PYREXIA (Fever). At the time of the report, RASH (rash on chest and back) outcome was unknown and PYREXIA (Fever) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant drug was not reported. Treatment medication was not reported.
edema on thighs made it difficult for the patient to walk; edema in stomach which persisted and moved around to other parts of the body; edema in stomach which persisted and moved around to other parts of the body; left arm soreness; edema in hip/ edema on thighs made it difficult for the patient to walk; This is a spontaneous report from a contactable consumer (patient). A 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in left arm, on 17Mar2021 at 02:30 PM (Batch/Lot Number: EN6205) (at the age of 77 years old) as dose 2, single for COVID-19 immunisation. Medical history included pulmonary arterial hypertension on Jul2020. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was previously administered the first dose of BNT162B2, intramuscularly, administered in left arm, on 21Feb2021 (Lot Number: EN6200) (at the age of 76 years old) as dose 1, single for COVID-19 immunisation. On an unspecified date in Mar2021, the patient experienced edema in stomach which persisted and moved around to other parts of the body, left arm soreness, and edema in hip. On 01Apr2021, the patient's edema on thighs made it difficult for the patient to walk. Clinical course of the events was as follows: The patient reported that she had edema in her stomach. She clarified the edema started a day or two after she had her second COVID-19 Vaccine shot on 17Mar2021, and the edema had persisted since that time. The patient said the edema had moved around since it started, from her stomach to her hip. She said last night (31Mar2021) she had elevated her feet and legs when she went to sleep, and when she woke up this morning, the liquid (edema) was located on the inside of her thighs. The patient said the edema on the inside of her thighs made it difficult for her to walk this morning. She said she was now lying on the sofa with her legs elevated, trying to see if the liquid (edema) would keep moving from the inside of her thighs. The patient went to a doctor, and the doctor had her scheduled for a sonogram of her tummy (abdomen) on 05Apr2021. The patient also had left arm soreness for about a week which completely resolved. Treatment: Declined any. The doctor won't do anything for her until all the test results are in. The patient underwent lab tests and procedures on 29Mar2021 which included unknown results of abdominal x-ray and blood work. The outcome of events edema in stomach which persisted and moved around to other parts of the body and edema in hip/edema on thighs made it difficult for the patient to walk was not recovered; the event left arm soreness was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Deep aching pain in elbow joint with pain radiating in upper and lower arm with weakness and swelling in elbow joint area and arm (left arm).
pt recvd vax & devel lt hand tenderness, pain on inject, & heavy feeling;
Information has been received from a registered nurse concerning a female patient who on 11-AUG-2008 was vaccinated IM with the first 0.5 mL dose of GARDASIL (lot # not reported) and on 11-AUG-2009 was vaccinated IM with the second 0.5 mL dose of GARDASIL (lot # 661046/0381X). It was reported that the patient received her second dose of GARDASIL a year after her first dose and 3 days later she woke up with very dry eyes. The patient went to her eye doctor who informed that this is a common side effect with GARDASIL. The patient was now experiencing droopy eye/eyes. At the time of the report, the patient had not recovered. Additional information has been requested.
Patient found down at home unresponsive on the floor.   EMS was summoned the patient was found to be in asystole.   EMS was able to get a heartbeat.   Pt intubated and transferred to hospital.   Shortly admission to ICU patient began having severe myoclonic jerking and seizures.   Patient was extubated and made no respiratory attempts.   Patient expired
Pt was diagnosed with hepatoblastoma shortly after vaccination, began chemotherapy. After about 4 weeks developed papules which developed into vesicles, DFA positive for varicella, confirmed as vaccine strain by CDC. Treated with IV acyclovir 20mg/kg q8h and lesions resolved over the next week.
PT CALLED AND JUST WANTED TO REPORT TO ME AFTER TALKING WITH HER DOCTOR THAT AFTER SHE RECEIVED THE VACCINE SHE HAD PAIN FROM THE TOP OF HER HEAD DOWN TO HER COLLAR BONE.
1.5 CM CONFLUENT RED PATCH RIGHT LAT. THIGH WHERE CHICKEN POX VACCINE WAS ADMINISTERED WITH LOW GRADE FEVER.
My blood sugar testing #s were averaging 109, 2 days after vaccine, the #s were averaging 155, the tests went down in numbers but after my second dose the are higher than ever. Second dose was given 3/11/2021. These are Fasting Blood sugar numbers.
9/9/04: Pt with temp 100.5, also feeding less, decreased activity that day. Pt then had generalized seizure evening of 9/9/04 was transported by parents around 7:30pm and then transferred to hospital for evaluation of seizure.